Tango Therapeutics, Inc 10-K for FY2022
Tango Therapeutics, Inc. (TNGX)
10-K
2023-03-27
For: 2022-12-31
View Original
Added on
April 08, 2026
About this 10-K
Tango Therapeutics, Inc filed this 10-K on March 27, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $24.86M
- down 32.9% from $37.04M a year earlier
- Net loss
- $108.18M
- compared with a net loss of $58.24M a year earlier
- Diluted EPS
- -$1.23
- compared with -$0.94 a year earlier